PM2.5, Fra2/LCN2, and Macrophage Ferroptosis in Asthma

Fine particulate matter with an aerodynamic diameter of 2.5 micrometers or less, commonly termed PM2.5, is an established environmental aggravator of asthma. Although airway oxidative stress and inflammatory-cell recruitment are well recognized consequences of exposure, the molecular events connecting particulate matter to iron-dependent cell death have remained incompletely defined. The reference study, Targeting the Fra2/LCN2 axis attenuates PM2.5-aggravated asthma by suppressing M2 macrophage ferroptosis, addresses this gap by positioning macrophage ferroptosis within a specific transcriptional and mitochondrial pathway.

The work was published in Redox Biology as volume 94, article 104235 in 2026. According to the reference study, PM2.5 activates the transcription factor Fos-related antigen 2, or Fra2, which directly increases expression of Lipocalin 2, or LCN2, in M2 macrophages. The resulting Fra2/LCN2 axis is associated with impaired mitophagy, intracellular iron accumulation, and a ferroptotic phenotype that contributes to airway inflammation and impaired lung function.

Study Background and Research Question

Macrophages are plastic immune cells whose polarization state can shape airway remodeling and inflammatory resolution. In the asthma model used in this study, PM2.5 disrupted the balance between inflammatory M1-like and alternatively activated M2-like macrophage populations. The investigators therefore asked whether the particulate exposure was doing more than changing macrophage abundance or phenotype: could it selectively make M2 macrophages vulnerable to ferroptosis, and if so, what pathway connected the environmental stimulus to iron dysregulation?

This question is important because ferroptosis is not equivalent to generic apoptosis or nonspecific oxidative injury. It involves iron-dependent membrane lipid oxidation and is strongly influenced by iron storage, mitochondrial quality control, and antioxidant defenses. LCN2 is relevant to this biology because it participates in iron handling and inflammatory signaling, while Fra2 is a redox-responsive transcriptional regulator. The study tested whether these factors form a causal pathway rather than simply serving as correlated markers.

Key Innovation from the Reference Study

The central innovation is the integration of three levels of explanation. First, the authors identify a macrophage compartment, particularly M2 macrophages, as a cellular site where PM2.5-associated ferroptosis may develop. Second, they connect LCN2 expression to direct transcriptional control by Fra2 rather than treating LCN2 as an isolated downstream marker. Third, they link this transcriptional event to mitophagy dysfunction, mitochondrial damage, and iron accumulation.

Mechanistically, the proposed sequence is PM2.5 exposure, Fra2 activation, Fra2 binding at the LCN2 promoter, and increased LCN2 expression. This is followed by reduced FTH1 and increased ACSL4 and PTGS2, a combination consistent with weakened iron sequestration and enhanced ferroptosis-associated lipid remodeling. The study further reports increased P62 and decreased LC3B, findings interpreted as impaired autophagic or mitophagic flux. The authors then move beyond association by using macrophage-specific LCN2 knockdown in mice to test whether interrupting the axis can reverse the phenotype.

Methods and Experimental Design Insights

The experimental design combined an in vivo model of asthma aggravated by PM2.5 with in vitro stimulation of macrophage systems. In mice, the investigators evaluated airway pathology using hematoxylin and eosin staining and mucus-associated changes using periodic acid-Schiff staining. Lung function measurements provided a physiological endpoint, while bronchoalveolar lavage fluid flow cytometry and tissue immunofluorescence assessed macrophage polarization through CD86 and CD206 signals.

For cell-based experiments, PM2.5-stimulated RAW264.7 and THP-1 macrophage models were examined by RT-qPCR for polarization-associated transcripts, including iNOS and CD206. Integrated multi-omics profiling was used to identify pathways enriched after exposure and to prioritize LCN2 as a central candidate regulator. This discovery phase was followed by chromatin immunoprecipitation-qPCR, which tested whether Fra2 occupied the LCN2 promoter. Transmission electron microscopy and functional assays added structural and biochemical evidence for mitochondrial injury and ferroptosis.

The causal arm used an adeno-associated virus serotype 9 vector to reduce LCN2 specifically in macrophages in vivo. This intervention allowed the investigators to ask whether LCN2 was necessary for the PM2.5-associated phenotype, rather than merely accompanying it. The figure descriptions in the published study report replicate-level analyses for key tissue, flow-cytometry, and gene-expression endpoints, including groups represented as n = 6 in selected assays.

Protocol Parameters

• In vivo exposure design: Reproduce the study’s asthma-plus-PM2.5 exposure sequence from the full methods section; the condensed report does not provide enough dosing detail to justify a new exposure schedule.
• Macrophage phenotyping: Use CD86 and CD206 as complementary flow-cytometry or immunofluorescence markers, while interpreting them as polarization-associated readouts rather than complete definitions of macrophage identity.
• Mechanism panel: Pair LCN2 and Fra2 measurements with FTH1, ACSL4, and PTGS2, since the reference study uses their coordinated changes to support a ferroptosis mechanism.
• Mitophagy assessment: Evaluate P62 and LC3B together with mitochondrial morphology or integrity assays. These markers alone do not establish flux, so structural or functional confirmation is advisable.
• Causal validation: Include LCN2 loss-of-function or rescue experiments when testing whether the Fra2/LCN2 relationship is necessary for PM2.5-induced macrophage injury.
• Data interpretation: Combine lung function, airway histology, macrophage composition, iron-related measurements, and ferroptosis markers rather than relying on a single endpoint.

Core Findings and Why They Matter

The first major finding was that PM2.5 aggravated airway pathology while disturbing macrophage polarization. Histological evidence showed inflammatory-cell infiltration and mucus-related airway changes, and the physiological measurements indicated impaired pulmonary function. The macrophage data suggested that the exposure altered both CD86-associated and CD206-associated populations in the lung and lavage compartment.

The second finding came from the multi-omics analysis. Ferroptosis-related pathways were significantly enriched after PM2.5 treatment, and LCN2 emerged as a regulatory hub. This result gave the study a testable molecular direction instead of leaving ferroptosis as a broad description of oxidative stress.

The third finding was direct transcriptional evidence. Fra2 was activated by PM2.5 and shown by ChIP-qPCR to bind the LCN2 promoter. The result supports a model in which an environmental particulate stimulus is translated into altered iron-handling and cell-death signaling through transcriptional regulation.

The fourth finding connected this axis to cellular damage. LCN2-associated changes included reduced FTH1, increased ACSL4 and PTGS2, P62 accumulation, and reduced LC3B. Together with mitochondrial abnormalities observed by transmission electron microscopy and functional assays, these data support a relationship between defective mitophagy, iron accumulation, and ferroptosis in M2 macrophages.

Finally, macrophage-specific LCN2 knockdown reversed the PM2.5-associated mitophagy defect and ferroptosis-related changes. It also attenuated airway inflammation and improved the lung-function phenotype in asthmatic mice. This rescue experiment is the study’s strongest evidence that the Fra2/LCN2 axis is functionally relevant and may be more informative than simply cataloging PM2.5-induced molecular changes.

Comparison with Existing Internal Articles

The internal article Illuminating Intracellular Iron provides a broader discussion of live-cell ferrous-ion detection and ferroptosis-oriented research strategy. Its relationship to the reference study is conceptual: both emphasize that intracellular iron should be measured as part of a mechanistic redox framework, not treated as an isolated endpoint. The asthma paper adds disease-specific evidence by identifying macrophage mitophagy and the Fra2/LCN2 axis as upstream regulators.

A more directly practical companion is FerroOrange: Live-Cell Fe²⁺ Detection Probe for Iron Research. That resource focuses on live-cell intracellular iron detection and assay implementation, whereas the reference paper establishes the biological question: whether PM2.5-driven Fe²⁺ accumulation accompanies macrophage ferroptosis. Used together, the two articles suggest an orthogonal workflow in which live-cell iron measurements complement gene-expression, mitochondrial, ultrastructural, and rescue data.

Limitations and Transferability

The findings are compelling but should not be interpreted as proof that every PM2.5-associated asthma phenotype is caused by M2 macrophage ferroptosis. PM2.5 is chemically heterogeneous, and particle composition, source, preparation, and exposure route may influence the response. The condensed study information also does not specify all exposure concentrations, timing details, allergen schedules, or the exact composition of the integrated multi-omics datasets. Those parameters are essential for reproducing the model.

Macrophage polarization markers also have biological limitations. CD86 and CD206 represent useful operational measurements but do not capture the full spectrum of macrophage states in inflamed human airways. Likewise, P62 and LC3B changes are consistent with altered autophagy or mitophagy but require flux-aware experiments for definitive interpretation. Ferroptosis should be distinguished from other forms of cell death using multiple orthogonal assays, including lipid-peroxidation and iron-handling measurements where appropriate.

Transfer from mice and immortalized or monocytic cell models to patients remains unresolved. The LCN2 knockdown rescue establishes pathway relevance in the reported model, but it does not yet show whether Fra2/LCN2 activity predicts human exposure responses or whether targeting the pathway is therapeutically safe. Human airway macrophages, exposure-relevant PM2.5 samples, and longitudinal clinical specimens would be useful for assessing generalizability.

Why this cross-domain matters, maturity, and limitations

Connecting an asthma mechanism to an Fe²⁺ fluorescent probe is useful because the reference study makes intracellular iron accumulation part of its causal interpretation. However, fluorescence-based Fe²⁺ detection should be treated as a complementary measurement, not a standalone diagnosis of ferroptosis. A probe signal can reflect the accessible or labile ferrous pool rather than total cellular iron, and it cannot by itself establish lipid peroxidation, defective mitophagy, or macrophage identity.

The most mature application is therefore a multimodal workflow: measure live-cell ferrous-ion changes, then compare them with FTH1, ACSL4, PTGS2, P62, and LC3B responses, mitochondrial integrity, and LCN2 perturbation. This approach can test whether iron changes track with the Fra2/LCN2 mechanism while preserving the distinction between correlation and causation. Dead-cell measurements require particular caution because live-cell probe performance and cellular compartmentalization may not apply after loss of membrane and metabolic integrity.

Research Support Resources

For researchers adapting this workflow, FerroOrange (Fe²⁺ indicator), SKU C8004, is a Fe²⁺ fluorescent probe designed for live-cell intracellular iron detection. Product information reports fluorescence enhancement after irreversible Fe²⁺ binding, with maximum excitation at 543 nm and emission at 580 nm, making it compatible with fluorescence microscopy Fe2+ assay formats, flow cytometry workflows, and microplate readers. It is not intended for dead cells; storage and prepared-solution handling should follow the product instructions. Results should be interpreted alongside ferroptosis and mitophagy assays in broader iron metabolism research.